Fusion oncoprotein forces cell fates toward rhabdomyosarcoma
- OPACC
- Nov 17, 2023
- 1 min read
Scientists at St. Jude Children’s Research Hospital showed that a fusion oncoprotein can drive molecularly indistinguishable rhabdomyosarcomas arising from both muscle and blood vessel cells.
Comments